These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19864349)

  • 21. Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report.
    Kim BK; Choi YS; Park YH; Lee SU
    J Korean Med Sci; 2011 Dec; 26(12):1638-41. PubMed ID: 22148004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon therapy for hepatitis B and C].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract]   [Full Text] [Related]  

  • 23. [Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C].
    de Ledinghen V; Brudieux E; Beylot-Barry M; Belleannee G; Doutre MS; Couzigou P
    Gastroenterol Clin Biol; 1997; 21(6-7):523-4. PubMed ID: 9295983
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New combination treatment for hepatitis C is more beneficial than standard therapy, study says.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Oct; 13(20):5-6. PubMed ID: 12599388
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 27. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
    MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis.
    Sayiner ZA; Eraydın A; Metin T; Özkaya M
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28951513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
    Si CW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon for hepatitis C patients with psychiatric disorders.
    Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
    [No Abstract]   [Full Text] [Related]  

  • 32. Interferon-alfa- and erythropoetin-associated cerebral vasoconstriction.
    Gaillard N; Mania A; Brunel H; Blanc F; Arquizan C
    Cephalalgia; 2009 Dec; 29(12):1340-3. PubMed ID: 19489889
    [No Abstract]   [Full Text] [Related]  

  • 33. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
    Bini EJ; Mehandru S
    Aliment Pharmacol Ther; 2006 Mar; 23(6):777-85. PubMed ID: 16556180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 35. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy.
    Jensen SL; Holmes R
    J Drugs Dermatol; 2003 Oct; 2(5):554-6. PubMed ID: 14558405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature.
    Ahmad U; Li X; Sodeman T; Daboul I
    Am J Ther; 2013; 20(5):585-7. PubMed ID: 21317616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ANRS HC 02 RIBAVIC: summary and recommandations].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S104-5. PubMed ID: 19375036
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
    Morasco BJ; Rifai MA; Loftis JM; Indest DW; Moles JK; Hauser P
    J Affect Disord; 2007 Nov; 103(1-3):83-90. PubMed ID: 17292481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII inhibitor associated with peginterferon.
    Herman C; Boggio L; Green D
    Haemophilia; 2005 Jul; 11(4):408-10. PubMed ID: 16011596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.